BioMarin Pharmaceutical
BMRN
#2005
Rank
ยฃ7.57 B
Marketcap
ยฃ39.19
Share price
-0.58%
Change (1 day)
-11.16%
Change (1 year)

P/S ratio for BioMarin Pharmaceutical (BMRN)

P/S ratio as of May 2026 (TTM): 3.17

According to BioMarin Pharmaceutical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.69. At the end of 2026 the company had a P/S ratio of 3.21.

P/S ratio history for BioMarin Pharmaceutical from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.21-9.43%
20253.55-20.63%
20244.47-40.5%
20237.51-18.18%
20229.184.45%
20218.792.68%
20208.56-4.11%
20198.92-12.33%
201810.2-14.62%
201711.9-6.55%
201612.8-32.91%
201519.05.92%
201418.0-2.43%
201318.448.85%
201212.438.95%
20118.9012.36%
20107.9235.37%
20095.85-2.4%
20085.99-78.8%
200728.358.38%
200617.9-42.79%
200531.241.13%
200422.1-16.81%
200326.6-2.43%
200227.2-60.02%
200168.1

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Sanofi
SNY
1.85-41.68%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
3.79 19.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
1.68-47.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
2.64-16.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
7.17 126.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalyst Pharmaceuticals
CPRX
6.47 104.00%๐Ÿ‡บ๐Ÿ‡ธ USA